Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases


Review

. 2021 Sep 15;2021:3149223.


doi: 10.1155/2021/3149223.


eCollection 2021.

Affiliations

Item in Clipboard

Review

Cristina Quispe et al.


Oxid Med Cell Longev.


.

Abstract

Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer’s or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions.

Conflict of interest statement

The authors declare no conflict of interests.

Figures


Figure 1



Figure 1

Turmeric (a) as a source of CUR; tautomeric forms of CUR (b): keto-form (B1) and enol-form (B2).


Figure 2



Figure 2

Biological activities of curcumin.


Figure 3



Figure 3

Protective effect of curcumin-loaded nanocarriers on various ailments in human body.

References

    1. Pulido-Moran M., Moreno-Fernandez J., Ramirez-Tortosa C., Ramirez-Tortosa M. Curcumin and health. Molecules. 2016;21(3):p. 264. doi: 10.3390/molecules21030264.



      DOI



      PMC



      PubMed

    1. Kumar S., Ahuja V., Sankar M. J., Kumar A., Moss A. C. Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews. 2012;10 doi: 10.1002/14651858.CD008424.pub2.



      DOI



      PMC



      PubMed

    1. Aggarwal B. B., Harikumar K. B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology. 2009;41:40–59. doi: 10.1016/j.biocel.2008.06.010.



      DOI



      PMC



      PubMed

    1. Ghasemian M., Owlia S., Owlia M. B. Review of anti-inflammatory herbal medicines. Advances in Pharmacological Sciences. 2016;2016 doi: 10.1155/2016/9130979.9130979



      DOI



      PMC



      PubMed

    1. Lee S.-Y., Cho S.-S., Li Y., Bae C.-S., Park K. M., Park D.-H. Anti-inflammatory effect of Curcuma longa and Allium hookeri co-treatment via NF-κB and COX-2 pathways. Scientific Reports. 2020;10:p. 5718. doi: 10.1038/s41598-020-62749-7.



      DOI



      PMC



      PubMed

Dies ist ein automatisch übersetzter Artikel. Er kann nur einer groben Orientierung dienen. Das Original gibt es hier: psoriasis

Schreibe einen Kommentar